CVRx (CVRX) Net Margin (2020 - 2026)
CVRx's quarterly Net Margin came in at 88.83% in Q1 2026, up 2265.0% year-on-year from 3.76% in Q1 2025, and down 19.1% quarter-over-quarter from 74.59% in Q4 2025.
CVRx has reported Net Margin for 7 years, with the latest figure at 88.83% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 2265.0% year-over-year to 88.83%; the trailing twelve-month figure through Mar 2026 stood at 89.18% (up 832.0% YoY), and the FY2025 full-year result was 94.13%, up 2278.0% from the prior year.
- Net Margin for Q1 2026 stood at 88.83%, down from 74.59% in the prior quarter.
- The five-year high for Net Margin was 69.42% in Q4 2024, with the low at 245.12% in Q1 2022.
- Average Net Margin over 5 years is 127.34%, with a median of 111.48% recorded in 2025.
- Year-over-year, Net Margin jumped 34824 bps in 2022 and plunged 6345 bps in 2024.
- Tracing CVRX's Net Margin over 5 years: stood at 146.82% in 2022, then jumped by 46 bps to 79.75% in 2023, then rose by 13 bps to 69.42% in 2024, then slipped by 7 bps to 74.59% in 2025, then decreased by 19 bps to 88.83% in 2026.
- The last three Net Margin figures came in at 88.83% (Q1 2026), 74.59% (Q4 2025), and 87.61% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | CVRx | 144.43 Mn | 72.13 Mn | 12.88 Mn | -88.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -88.83% |
| Dec 31, 2025 | -74.59% |
| Sep 30, 2025 | -87.61% |
| Jun 30, 2025 | -108.44% |
| Mar 31, 2025 | -111.48% |
| Dec 31, 2024 | -69.42% |
| Sep 30, 2024 | -97.95% |
| Jun 30, 2024 | -118.82% |
| Mar 31, 2024 | -206.00% |
| Dec 31, 2023 | -79.75% |
| Sep 30, 2023 | -85.73% |
| Jun 30, 2023 | -122.64% |
| Mar 31, 2023 | -142.55% |
| Dec 31, 2022 | -146.82% |
| Sep 30, 2022 | -158.91% |
| Jun 30, 2022 | -220.06% |
| Mar 31, 2022 | -245.12% |
| Dec 31, 2021 | -288.96% |
| Sep 30, 2021 | -180.65% |
| Jun 30, 2021 | -568.30% |
| Mar 31, 2021 | -301.64% |
| Dec 31, 2020 | -162.93% |
| Sep 30, 2020 | -323.67% |
| Jun 30, 2020 | -293.36% |